EIF2AK1 (HRI), actif, GST étiqueté humain, PRECISIO, recombinant, exprimé en cellules bactériulovirus infectées Sf9, >= 70% (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5321-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Eukaryotic translation initiation factor 2-α kinase 1 (EIF2AK1) modulates protein synthesis. It acts at the level of translation initiation to downreg...


en savoir plus

Votre prix
$517.74 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Eukaryotic translation initiation factor 2-α kinase 1 (EIF2AK1) modulates protein synthesis. It acts at the level of translation initiation to downregulate protein synthesis in response to stress. The protein is activated by heme deficiency and other stimuli and is a major protein kinase that phosphorylates EIF2-α. EIF2AK1 is downregulated in the majority of ovarian cancers compared with normal ovarian tissues. It functions in iron homeostasis and may play a role in hemolytic and inflammatory anemia.

General description

Eukaryotic translation initiation factor 2-α kinase 1 (EIF2AK1) or HRI is a kinase that can be inactivated by hemin. The gene encoding this protein is localized on human chromosome 7p22.1.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM glutathione, 0.1 mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, 25% glycerol.

Preparation Note

After opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles.

application(s)cell analysis
assay≥70% (SDS-PAGE)
biological sourcehuman
formbuffered aqueous glycerol solution
Gene Informationhuman ... EIF2AK1(27102)
mol wt~120 kDa
NCBI accession no.NM_014413
product linePRECISIO®
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity9.6-14.4 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: